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Proteins belonging to the Bcl-2 family function as regulators of ‘life-or-death’ decisions in response to various intrinsic and extrinsic
stimuli. In mammals, cell death is controlled by pro- and anti-apoptotic members of the Bcl-2 family, which function upstream of the caspase
cascade. Structural and functional homologues of the Bcl-2 family proteins also exist in lower eukaryotes, such as nematodes and flies. In
nematodes, an anti-apoptotic Bcl-2 family protein, CED-9, functions as a potent cell death inhibitor, and a BH3-only protein, EGL-1, acts as
an inhibitor of CED-9 to facilitate the spatio-temporal regulation of programmed cell death. On the other hand, the Drosophila genome
encodes two Bcl-2 family proteins, Drob-1/Debcl/dBorg-1/dBok and Buffy/dBorg-2, both of which structurally belong to the pro-apoptotic
group, despite abundant similarities in the cell death mechanisms between flies and vertebrates. Drob-1 acts as a pro-apoptotic factor in vitro
and in vivo, and Buffy/dBorg-2 exhibits a weak anti-apoptotic function. The ancestral role of the Bcl-2 family protein may be pro-apoptotic,
and the evolution of the functions of this family of proteins may be closely linked with the contribution of mitochondria to the cell death
pathway.
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The molecular mechanisms of programmed cell death are
highly conserved throughout evolution. The Bcl-2 family
proteins are key regulators of this process. Each member of
the Bcl-2 family possesses at least one of four Bcl-2 homol-
ogy (BH) domains. Structurally, the Bcl-2 family is com-
prised of two subgroups, multi-domain (three or four BH
domains) and BH3-only Bcl-2 family proteins. The group of
multi-domain Bcl-2 family proteins consists of both pro- and
anti-apoptotic members, whereas BH3-only proteins are pro-
apoptotic. In mammalian cells, pro- and anti-apoptotic mem-
bers of the Bcl-2 family act as molecular determinants for cell
death decisions. Genetic and biochemical studies in the
nematodeCaenorhabditis elegans (C. elegans) have revealed
that worm cell death is also regulated by two opposing
members of the Bcl-2 family, EGL-1 and CED-9. In contrast,0167-4889/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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Medicine, 295 Congress Avenue, New Haven, CT 06536, USA.Drosophila possesses two Bcl-2 family genes, both of which
encode proteins homologous to themammalian pro-apoptotic
Bcl-2 family member Bok/Mtd. In this review, we describe
the roles and the functions of the Bcl-2 family proteins in
invertebrates. We also discuss the evolution of this cell death
pathway, which may be closely linked with the roles of the
mitochondria and the Bcl-2 family proteins.2. Bcl-2 family proteins in C. elegans
2.1. Genetic identification of ced-9
In C. elegans, 131 of the 1090 somatic cells generated
during development undergo programmed cell death. All the
cell death in C. elegans is regulated by three genes: ced-3,
ced-4, and ced-9. A loss-of-functionmutation of ced-3 or ced-
4 prevents all 131 programmed cell deaths [1]. The ced-3
gene product is a homologue of mammalian interleukin-1h-
converting enzyme (ICE), which is a member of a unique
cysteine protease family, the caspases. CED-4 is an adaptor
protein homologous to apoptotic protease activating factor-1
(Apaf-1). CED-9 is an ortholog of the anti-apoptotic mem-
bers of the Bcl-2 family. Genetic studies have shown that the
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ced-3 and ced-4 activities (Fig. 1) [2]. The normal
programmed cell death in C. elegans is prevented by a
gain-of-function mutation (n1950) of the ced-9 gene, just as
it is by a ced-3 or ced-4 loss-of-function mutant.
Gain-of-function mutations of egg-laying defective-1
(egl-1) cause the death of hermaphrodite-specific neurons
(HSNs) in a ced-3-dependent manner [3]. The deaths of
HSNs in egl-1 mutants are prevented in egl-1, ced-9
(n1950) double mutants, and the egg-laying behavior in
the double mutants is also normal. This indicates that the
prevention of HSN death by the ced-9 (n1950) mutation
results in the survival of functional neurons. In contrast to
the n1950 allele of ced-9, loss-of-function mutations in the
ced-9 gene cause ectopic cell deaths resulting in embryonic
lethality. These cell deaths are prevented by a loss-of-
function mutation in ced-3 or ced-4, suggesting that ced-9
normally acts upstream of ced-3 or ced-4 to suppress cell
death. The expression levels of ced-3 and ced-4 mRNA in
the embryos are very high [4,5], suggesting that their
expression is not limited to dying cells. Thus, the machin-
ery of programmed cell death is present not only in cells
undergoing programmed cell death but also in living cells.
The triggering of the cell death machinery may be nega-
tively controlled by the ced-9 gene product.
2.2. Molecular cloning of the ced-9 gene
The ced-9 genomic region was mapped using a restric-
tion fragment length polymorphism, and the ced-9 gene was
identified in microinjection experiments as the rescuing
gene of the lethal phenotype of loss-of-function (lf) ced-9Fig. 1. Models for the intrinsic cell death pathways in C. elegans, Drosophila, and
with the role of mitochondria in the cell death pathway. For details see text.mutant animals [6]. Analysis of the gene structure and
transcripts of the ced-9 region suggested that ced-9 lies in
a polycistronic locus. This locus also contains a gene similar
to bovine cytochrome b560, which is an inner mitochondrial
protein involved in system II of the mitochondrial electron
transport chain; however, the role of this gene in prog-
rammed cell death is unknown. The ced-9 gene expresses a
1.3-kb mRNA that is highly expressed in embryos. The ced-
9 mRNA encodes a protein of 280 amino acids that shows a
23% identity with human Bcl-2. The overexpression of Bcl-
2 has been shown to protect cells from apoptosis in a
number of experimental systems, including the deaths of
neurons induced by neurotrophic factor withdrawal and of
certain hematopoietic cell lines induced by cytokine dep-
rivation. The overexpression of CED-9 prevents not only
ectopic cell death in ced-9 (lf) mutants but also much of
the programmed cell death normally observed during
development. The overexpression of human Bcl-2 can
partially prevent ectopic cell death in ced-9 (lf) mutants
as well as preventing normal programmed cell death [7].
Furthermore, the overexpression of human Bcl-2 prevents
CED-3- or ICE-induced cell death in rat fibroblasts [8].
These results strongly suggest that the pathway of prog-
rammed cell death that utilizes CED-9/Bcl-2 and CED-3/ICE
as negative and positive regulators is conserved throughout
evolution.
2.3. Interactions of CED-3, CED-4, and CED-9
CED-3, CED-4, and CED-9 are common mediators of
cell death in C. elegans. How do these three proteins interact
to regulate cell death in nematodes? Overexpression ofmammals. The evolution of the Bcl-2 family proteins may be closely linked
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required for this killing activity, suggesting that CED-4 acts
upstream of CED-3 [9]. CED-9 can prevent the cell death
induced by CED-3, and this anti-apoptotic activity of CED-
9 requires CED-4, suggesting that CED-9 acts at least in part
through CED-4 to prevent CED-3-induced cell death. It has
also been shown that CED-9 can be a substrate of the CED-
3 protease, thereby inhibiting CED-3 activity by analogy
with baculoviral caspase inhibitor, P35 [10].
These three proteins interact with each other not only
genetically but also physically. A search for the binding
partners of CED-4 in a yeast two-hybrid screen identified
CED-9 as an interacting protein [11]. CED-4 and CED-9
associate physically with each other in yeast and in
mammalian cells. This interaction is eliminated if CED-9
loss-of-function mutants are used in the binding assay [11],
suggesting the CED-9/CED-4 interaction is crucial for the
anti-apoptotic function of CED-9. When CED-3, CED-4,
and CED-9 are simultaneously overexpressed in mamma-
lian cells, they form a multimeric protein complex [12,13].
This complex is called the ‘‘apoptosome’’ [14]. CED-3
cannot interact with CED-9 in the absence of CED-4,
suggesting that CED-3 associates with CED-9 through
CED-4. The overexpression of wild-type, but not a loss-
of-function mutant of CED-4, promotes the cell death-
inducing activity of CED-3 in mammalian cells. This pro-
apoptotic activity of CED-4 requires the presence of
functional CED-3 and can be prevented by overexpressing
CED-9. Furthermore, CED-9 can prevent the CED-4-me-
diated enzymatic activation of CED-3. Thus, the CED-3
activity is regulated by CED-4 and CED-9 through their
physical interactions (Fig. 1).
2.4. Initiation of worm cell death by the BH3-only protein
EGL-1
The Bcl-2 family of proteins shares up to four Bcl-2
homology domains (BH1–4), the common characteristic
features of this family. It is known that a nine-amino acid
stretch, the BH3 domain, is crucial for the cell-killing ability
of the pro-apoptotic family members. Some pro-apoptotic
members have only a BH3 domain; these are called BH3-
only proteins.
egl-1 encodes a protein that belongs to the BH3-only
protein subfamily, and its expression is observed only in
dying cells. The activity of EGL-1 is controlled at the
transcriptional level. A genetic screen for dominant sup-
pressors of the cell death phenotype of gain-of-function (gf)
egl-1 mutants (ex. n1084) identified a semidominant sup-
pressor, egl-1 (n3082) [3]. The n3082 mutation of egl-1
blocks not only the death of HSNs in egl-1 (gf) mutants but
also the cell death that occurs during normal development,
just as in ced-4 (lf), ced-3 (lf), and ced-9 (gf) mutants.
Ectopic expression of EGL-1 causes cell death that can
be completely prevented by a ced-3 or ced-4 loss-of-func-
tion mutation, suggesting that EGL-1 functions upstream ofCED-3 and CED-4 (Fig. 1A). EGL-1-induced cell death is
suppressed by the ced-9 (gf) mutation, whereas the egl-1 (lf)
mutation does not rescue the lethality of the ced-9 (lf)
mutant, suggesting EGL-1 acts upstream of or in parallel
to CED-9. The n1950 mutation in the ced-9 gene prevents
most programmed cell death. This mutant encodes a CED-9
protein with a glycine to glutamate substitution at position
169 (G169E), which is located within the highly conserved
BH1 region. CED-9 (G169E) can bind to CED-4 similarly
with wild-type CED-9, and can weakly bind to EGL-1. In
contrast to wild-type CED-9, the interaction between CED-9
(G169E) and CED-4 is not disrupted by EGL-1. EGL-1
induces the release of CED-4 from the CED-9/CED-4
complex but not from the CED-9 (G169E)/CED-4 complex
both in vitro and in mammalian cells [15,16]. The ability of
EGL-1 to promote mammalian cell death is impaired by
replacing wild-type CED-9 with CED-9 (G169E) [15].
Based on homology modeling of the CED-9/EGL-1 com-
plex, second-site compensatory mutations in EGL-1 that
partially restore the binding of EGL-1 and CED-9 (G169E)
complexes were generated. These EGL-1 mutants signifi-
cantly suppressed the anti-death activity of CED-9 (G169E)
in vivo [16]. These studies suggest that the release of CED-4
from the CED-4/CED-9 complex by EGL-1 is necessary to
initiate cell death in C. elegans.
2.5. Subcellular localization of CED-4 and CED-9
The expression profile and subcellular localization of
CED-9 have been studied using an anti-CED-9 antibody
[17]. CED-9 expression can be detected as early as the two-
cell stage, and it peaks at the 200-cell stage. After this point,
the expression gradually decreases, and it is undetectable at
around the time of hatching. There is no detectable expres-
sion in the larvae or adults. Intracellularly, CED-9 localizes
to the mitochondria in the embryos. Similar to CED-9,
CED-4 expression first appears at the 100-cell stage, persists
through embryogenesis, and is undetectable in both the
larvae and adults. The subcellular localization of CED-4 is
also similar to that of CED-9. Loss-of-function mutations of
ced-4, ced-3, or egl-1 do not affect the localization of CED-
9. The localization of CED-4 is also not affected by a loss-
of-function mutation of ced-3 or egl-1. In contrast, in the
genetic background of loss-of-function ced-9, CED-4 does
not exhibit mitochondrial localization, but is instead local-
ized to the nuclear membrane. The overexpression of EGL-1
does not affect the localization of CED-9, but triggers the
translocation of CED-4 from the mitochondria to the nuclear
membrane. In the absence of CED-9, EGL-1 is not required
for the localization of CED-4 to the nuclear membrane.
These observations indicate that EGL-1 promotes CED-4
translocation by antagonizing the activity of CED-9. A loss-
of-function mutation of CED-4, P23L, strongly reduces
CED-4’s ability to bind CED-9. CED-4 (P23L) fails to
associate with either the mitochondria or the nuclear mem-
brane, suggesting that CED-4 is actively recruited to both.
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3.1. Cell death machinery in Drosophila
The components of the cell death pathway are highly
conserved throughout evolution among C. elegans, Dro-
sophila, and mammals (Fig. 1) [18,19]. In Drosophila, as
well as in mammals, cell death is essential for normal
embryogenesis and organ development, especially in the
central nervous system, and is also important for metamor-
phosis. Similar to the mammalian cell death machinery,
Drosophila possesses a more-complicated cell-death regu-
latory system than do nematodes: the fly has an Apaf-1-like
protein (Dark/Dapaf-1/HAC1) [20–22], seven caspases
[23–29], and two Bcl-2 family members (Fig. 1) [30–33].
Drosophila also has unique killer proteins, Reaper, Hid, and
Grim [34–36]. A deficiency of all three of these proteins
eliminates all the cell death during embryogenesis, resulting
in embryonic lethality [34]. Genetic studies have demon-
strated that Dark and the caspases function downstream of
Reaper, Hid, and Grim, and that the overexpression of any
of these proteins is sufficient to induce cell death. The
activities of Reaper and Grim are regulated at the transcrip-
tional level, while Hid can be inactivated by phosphoryla-
tion that is mediated by Ras/MAPK signaling [37,38]. These
proteins can directly bind and inhibit the Drosophila cas-
pase inhibitor DIAP1 [39]. Several lines of evidence indi-
cate that the mechanism by which these proteins inhibit
DIAP1 include the down-regulation of the DIAP1 protein
through the ubiquitin–proteasome pathway and the transla-
tional inhibition of DIAP1 [40–46]. Mammalian mitochon-
drial IAP inhibitors, such as Smac/DIABLO and HtrA2/
Omi, are thought to be functional orthologs of Reaper, Hid,
and Grim. Sickle, another Drosophila killer protein, shares
N-terminal residues in common with other killer proteins in
flies (Reaper, Hid and Grim) and mammals (Smac/DIABLO
and HtrA2/Omi) [47–49]. Sickle can induce cell death by
antagonizing DIAP1 function through its N-terminus. In
addition to the intrinsic cell-death system, Drosophila has
an extrinsic pathway that is mediated by the tumor necrosis
factor (TNF) ligand and its receptor; Eiger is a Drosophila
TNF homologue that triggers the JNK pathway [50–52] and
Wengen is a TNF receptor homologue mediating Eiger
signaling [52,53]. Thus, Drosophila possesses intrinsic
and extrinsic cell death systems that are closely related to
the systems seen in mammals. Hence, genetic studies of
cell-death molecules in flies should be very helpful for
dissecting their evolutionarily conserved functions, as well
as to understand their ancestral roles.
3.2. Drosophila Bcl-2 family members
In 2000, two Bcl-2 family members were identified in
Drosophila by several independent groups and termed
Drob-1/Debcl/dBorg-1/dBok and Buffy/dBorg-2 [30–33].
In this review, we will call the former protein Drob-1, whichwas the name used in the first report, unless we need to
identify this protein by its other names.
A search for Bcl-2 family members in the Drosophila
expressed sequence tag (EST) database identified two
genes, drob-1 and buffy/dborg-2. Intriguingly, both of the
proteins structurally belong to the multi-domain pro-apo-
ptotic Bcl-2 subfamily, and show the highest homology
with mammalian Bok/Mtd (Fig. 2A). A model of the
predicted dBok protein structure suggests dBok belongs to
the pore-forming group of pro-apoptotic Bcl-2 family
proteins, which includes Bax, Bak, and Bok/Mtd [33].
Drob-1 has BH1, BH2, and BH3 domains, and a weak
BH4 domain, as well as a C-terminal transmembrane
domain (Fig. 2A). Consistent with the structural similarity,
Drob-1 has been shown to be a killer protein in vitro and in
vivo. Overexpression of Drob-1 induces cell death both in
Drosophila and mammalian cells, and also in various
Drosophila larval tissues. Ectopically expressed Drob-1
localizes to the mitochondria (Fig. 2B), and a mutant
Drob-1 protein that lacks the C-terminal transmembrane
domain loses both the mitochondrial localization and cell-
killing ability, indicating that Drob-1 triggers the cell death
pathway at the mitochondrial level [30]. Although neither
Drob-1- nor dBok-induced cell death is inhibited by caspase
inhibitors, Debcl- or dBorg-1-induced cell death was sup-
pressed by them [30–33]. This discrepancy may be due to
different expression levels obtained by the different research
groups or to the different assay systems used for determin-
ing cell death. Other possibilities include the activation of
P35-resistant Drosophila caspase, DRONC, or the induction
of caspase-independent cell death through mitochondrial
caspase-independent cell death factors or mitochondrial
dysfunction. Supporting the latter possibility, it has been
reported that the mammalian counterparts of Drob-1, Bax or
Bak, can induce cell death that cannot be blocked by
caspase inhibitors [54,55]. Similar to Drob-1, an overex-
pression of Buffy/dBorg-2 in S2 cells can also induce cell
death, although the potential cell-killing ability is less than
that of Drob-1 (T.I. and M.M., unpublished data). In
contrast to our in vitro experiments, a recent study has
shown that Buffy acts as an anti-apoptotic factor in vivo
[56]. Although Buffy/dBorg-2 does not have an obvious
BH4 domain, which is a crucial domain for anti-apoptotic
Bcl-2 family members, the cell cycle inhibitory function has
been conserved between Buffy and mammalian Bcl-2 [56].
It will be important to dissect the mechanism of the anti-
apoptotic action of Buffy in vivo.
drob-1 mRNA is highly expressed in the early-stage
embryo with a large contribution of maternal transcript,
and it can be detected at all stages of Drosophila
development. The expression pattern of drob-1 in the
embryos, larval tissues, and adult ovaries correlates with
the distribution of TUNEL-positive dying cells [31].
Moreover, an RNAi-mediated inactivation of drob-1 in
early-stage embryos results in reduced cell death and
excess glial cells [31,32]. These observations demonstrate
Fig. 2. (A) Schematic structures of the evolutionarily conserved Bcl-2 family proteins in Drosophila (Drob-1 and Buffy/dBorg-2), Anopheles (agCG44751 and
agCG44761) and mammals (Bok/Mtd). BH1, BH2, BH3, the first a-helix (a1), and transmembrane (TM) domains are represented. a1 is structurally related to
BH4 domain, and we represent the region as ‘weak BH4’ domain. TM domain is not apparent in the predicted sequence of agCG44761 (see Fig. 3). (B) HA-
Drob-1 was overexpressed in COS7 cells, and the cells were stained with an anti-HA antibody. Mitochondria was visualized by Mitotracker staining. Merged
images of Drob-1- and Mitotracker-stained cells showed that Drob-1 predominantly localized to mitochondria.
T. Igaki, M. Miura / Biochimica et Biophysica Acta 1644 (2004) 73–81 77that Drob-1 functions physiologically as a pro-apoptotic
factor, at least in these cells. The mechanisms of Drob-1’s
activation in response to cell-death stimuli remain to be
elucidated.
In addition to its pro-apoptotic function, Drob-1 can also
promote cell survival under some conditions. Brachmann et
al. [32] have shown that S2 cell death induced by the
overexpression of CED-3 or by serum deprivation could
be rescued by the overexpression of dBorg-1. We (Drob-1)
and Colussi et al. [31] (Debcl) have used an N-terminally
HA-tagged protein to characterize the functions of this
protein, whereas Brachmann et al. have analyzed the func-
tion of untagged dBorg-1. One possible explanation for the
different results is that the N-terminus of Drob-1, like
mammalian Bax, may negatively regulate its pro-apoptotic
activity, and the N-terminal tag may disrupt this function,
changing it into a constitutively active form. Supporting this
idea, Zhang et al. [33] have reported that the dBok protein,
which lacks the N-terminal 86 amino acids of Drob-1/
Debcl/dBorg-1, kills cells efficiently.
Genes encoding obvious anti-apoptotic Bcl-2 proteins
have not been found in the fly genome. It is possible that
anti-apoptotic Bcl-2 proteins with the BH4 domain do not
exist in flies, and are acquired through the evolution of the
cell death machinery. Alternatively, pro-survival Bcl-2
family members may exist that have low sequence homol-
ogy to the known proteins; alternatively, Drob-1 and/orBuffy/dBorg-2 may be converted context dependently into
an anti-apoptotic form by alterations such as posttransla-
tional modifications [32,56]. The first possibility indicates
that Bcl-2 family members with a pro-apoptotic function
are prototypical of this protein family. It is known that the
mechanism of cell death inhibition by CED-9 is different
from that of mammalian Bcl-2 proteins. In mammals, anti-
apoptotic Bcl-2 family proteins block the mitochondrial
release of cytochrome c by antagonizing pro-apoptotic Bcl-
2 family members or by directly preventing the mitochon-
drial permeability transition. In contrast, nematode CED-9
directly binds to CED-4, thereby inhibiting CED-4’s ability
to activate CED-3 (Fig. 1). Thus, the involvement of the
mitochondria in cell death regulation may be closely linked
with the evolution of the Bcl-2 family proteins.4. Evolutionarily conserved cell death pathways
mediated by Bcl-2 family proteins
4.1. Role of mitochondria in the cell death pathway
In the mammalian cell death pathway, mitochondria
play critical roles in determining the ‘survival-or-death’
decision upstream of the caspase cascade. Mitochondria
possess apoptogenic factors such as cytochrome c [57],
Smac/DIABLO [58,59], and HtrA2/Omi [60–64] in their
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cytosol upon receipt of a cell death signal, thereby facil-
itating caspase activation by stimulating a caspase activa-
tor, Apaf-1, or inactivating caspase inhibitors, the IAPs.
Other apoptogenic factors that normally exist in the
mitochondria are AIF [65] and EndoG [66,67], which
translocate to the nucleus in response to cell death stimuli,
facilitating the DNA fragmentation. Interestingly, AIF and
EndoG have been shown to function in a single mitochon-
dria-initiated apoptotic DNA degradation pathway in C.
elegans [68]. In mammals, the release of cytochrome c is
necessary for the formation of the apoptosome and the
subsequent activation of caspase-9. Accumulating studies
indicate that the molecular determinants for the release of
cytochrome c are anti-apoptotic and pro-apoptotic Bcl-2
family proteins (Fig. 1).
The Drosophila genome encodes orthologs of the apop-
togenic molecules that reside in the mitochondria, including
orthologs of cytochrome c, HtrA2/Omi, AIF, and EndoG. In
fact, cytochrome c can activate Drosophila caspases in
embryonic lysates [21]. Although cytochrome c release
can be detected in digitonin extracts of apoptotic S2 cells
[21], it has also been shown that cytochrome c is not
released from the mitochondria but rather its form is altered
to expose a new epitope during apoptosis [69]. Interestingly,
a significant proportion of the Drosophila cellular caspase
DRONC, a functional counterpart of caspase-9, and drICE,Fig. 3. Alignment of the amino acid sequences of Drob-1, agCG44751, Buffy/dBo
and positively charged residues are highlighted in yellow and green, respectively.
putative transmembrane (TM) region are shown.a Drosophila effector caspase, has been shown to localize
near mitochondria, suggesting that an apoptosome may form
in the vicinity of mitochondria in the absence of cytochrome
c release in flies (Fig. 1) [70]. In addition, Drosophila
cytochrome c has been shown to be important for fly
caspase activation during spermatogenesis [71]. However,
RNAi experiments have shown that cytochrome c is not
required for stress-induced S2 cell death [72]. Thus, the
involvement of cytochrome c in Drosophila cell death
remains to be clarified.
4.2. Bcl-2 family members in the mosquito
In 2002, the complete genome of the mosquito Anoph-
eles gambiae, the mediator of the malaria parasite, was
published. Like Drosophila, Anopheles also has two Bcl-2
family genes that both belong to the multi-domain pro-
apoptotic subfamily. We cloned the cDNA of one of these
genes, agCG44751, from Anopheles Sua5.1* cells. The
other gene has been also predicted from Anopheles genome
as agCG44761. The amino acid sequences of these gene
products show the highest homologies with Drob-1 and
Buffy/dBorg-2, respectively (Fig. 3). Intriguingly, the mos-
quito genome apparently does not encode a homologue of
Reaper, suggesting that other cell-death triggering mole-
cules, such as these two Bcl-2 family proteins, play a large
role in the Anopheles cell death machinery.rg-2, and agCG44761. Hydrophobic residues are shown in blue. Negatively
The conserved BH1, BH2, BH3, and the first a-helix (a1) regions and the
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proteins
Mice deficient for Bax and Bak, multi-domain pro-
apoptotic Bcl-2 family members, exhibit severe develop-
mental defects due to the lack of cell death [73]. This
suggests that the pro-apoptotic function of the Bcl-2 family
members is essential for the normal development and
viability of mammals. On the other hand, cell death is not
essential for the survival of nematodes. As outlined above,
the nematode multi-domain Bcl-2 family member, CED-9,
functions as a cell death inhibitor. In addition to its pro-
survival function, CED-9 may also possess a pro-apoptotic
function. In the genetic background of a weak ced-3 allele
(n2427), a reduction in ced-9 activity results in more extra
cells than are seen in the ced-3 (n2427) phenotype in the
anterior pharynx [74]. In this situation, EGL-1 may act as an
activator for CED-9.
Drosophila is a suitable model organism to understand
the evolutionarily conserved roles of the pro-apoptotic Bcl-2
family proteins. In flies, DIAP1 is essential for preventing
cell death during embryogenesis, and down-regulation of
DIAP1 is sufficient to induce cell death in S2 cells
[72,75,76]. This suggests that the anti-death regulation in
Drosophila may strongly depend on IAPs but not on Bcl-2
family proteins. As described in this review, the pro-apo-
ptotic function of the Bcl-2 family is well conserved
throughout evolution. Genetic studies of loss-of-function
mutants of Drob-1 and Buffy/dBorg-2 will help dissect the
ancestral roles of the Bcl-2 family proteins and may also
provide new insights into the evolution of cell-death regu-
latory mechanisms that are mediated through mitochondria.Acknowledgements
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